Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest-specific 2-like protein 1 is a multifunctional, evolutionarily conserved protein serving as a cytoskeletal cross-linker by binding both filamentous actin and microtubules via its calponin-homology (CH) and GAS2-related (GAR) domains. This enables GAS2L1 to regulate microtubule stability, guide microtubule growth along actin stress fibers, and contribute to the organization of stress fibers, focal adhesions, and cytoskeletal integrity. GAS2L1 localizes to the proximal end of mature centrioles, linking centrosomes to both microtubules and actin, and participates in proper centrosome disjunction, spindle assembly, and chromosome segregation. GAS2L1's activity is regulated through autoinhibition involving domain interactions, which is relieved by phosphorylation (e.g., at Ser352 by Nek2 during mitosis). There are isoforms of GAS2L1 resulting from alternative splicing, but its structure and function are mostly conserved within the GAS2 protein family. While GAS2L1 influences cell cycle and cytoskeletal organization, it is not currently a direct target for drug development or clinical intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest-specific 2-like protein 1 (GAS2L1).